KLS-13019
id:
kls-13019-4-146755
title:
KLS-13019
text:
KLS-13019 is a cannabidiol derivative that has been modified on the side chain to improve solubility and tissue penetration properties. It was developed and patented by Neuropathix subsidiary Kannalife and found to be 50x more potent than cannabidiol as a neuroprotective agent, thought to be mediated by modulation of the sodium-calcium exchanger channel. It also had a higher therapeutic index than cannabidiol. Both KLS-13019 and cannabidiol, prevented the development of CIPN, while only KLS-1301
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/KLS-13019
date created:
date modified:
2023-08-14T13:56:31Z
main entity:
{"identifier":"Q98594567","url":"https://www.wikidata.org/entity/Q98594567"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/68/KLS-13019_structure.png","width":1217,"height":642}
fields total:
13
integrity:
15